Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 44, 2010 - Issue 5
Submit an article Journal homepage
126
Views
9
CrossRef citations to date
0
Altmetric
Urology

Increased expression of elongation factor-1α is significantly correlated with poor prognosis of human prostate cancer

Huaizheng Liu Department of Urology, Xiang Ya Hospital, Central South University, PR ChinaCorrespondence[email protected]
,
Jian Ding Department of Urology, Xiang Ya Hospital, Central South University, PR China
,
Fang Chen Department of Urology, Xiang Ya Hospital, Central South University, PR China
,
Benyi Fan Department of Urology, Xiang Ya Hospital, Central South University, PR China
,
Ning Gao Department of Urology, Xiang Ya Hospital, Central South University, PR China
,
Zhongqing Yang Department of Urology, Xiang Ya Hospital, Central South University, PR China
&
Lin Qi Department of Urology, Xiang Ya Hospital, Central South University, PR China
 show all
Pages 277-283 | Received 18 Dec 2009, Accepted 04 May 2010, Published online: 14 Jun 2010

References

  • Kakehi Y. Watchful waiting as a treatment option for localized prostate cancer in the PSA era. Jpn J Clin Oncol 2003;33:1–5.
  • Rubin MA. Targeted therapy of cancer: new roles for pathologists – prostate cancer. Mod Pathol 2008;21(Suppl 2):S44–55.
  • Graham J, Baker M, Macbeth F, Titshall V. Guideline Development Group. Diagnosis and treatment of prostate cancer: summary of NICE guidance. BMJ 2008;336:610–2.
  • Cuzick J, Fisher G, Kattan MW. Long-term outcome among men with conservatively treated localised prostate cancer. Br J Cancer 2006;95:1186–94.
  • Kattan MW, Cuzick J, Fisher G. Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent. Cancer 2008;112:69–74.
  • Wang W, Lin T, Huang J, Hu W, Xu K, Liu J. Analysis of Mel-18 expression in prostate cancer tissues and correlation with clinicopathologic features. Urol Oncol 2009; Apr 21. doi: 10.1016/j.urolonc.2009.02.004. [Epub ahead of print.].
  • Kurasawa Y, Hanyu K, Watanabe Y, Numata O. F-actin bundling activity of Tetrahymena elongation factor 1α is regulated by Ca2+/calmodulin. J Biochem 1996;119:791–8.
  • Liu G, Edmonds BT, Condeelis J. EF-1α and the cytoskeleton. Trends Cell Biol 1996;6:168–71.
  • Browne GJ, Proud CG. Regulation of peptide-chain elongation in mammalian cells. Eur J Biochem 2002;269:5360–8.
  • Tomlinson VA, Newbery HJ, Wray NR. Translation elongation factor EF1a2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours. BMC Cancer 2005;5:113.
  • Taniguchi S, Miyamoto S, Sadano H, Kobayashi H. Rat elongation factor 1 alpha: sequence of cDNA from highly metastatic fos transferred cell line. Nucl Acids Res 1992;19:6949.
  • Pencil SD, Toh Y, Nicolson GL. Candidate metastasis associated genes of the rat 13762NF mammary adenocarcinoma. Breast Cancer Res Treat 1993;25:165–74.
  • Seaward SA, Weinberg V, Lewis P, Leigh B, Phillips TL, Roach M III. Improved freedom from PSA failure with whole pelvic irradiation for high-risk prostate cancer. Int J Radiat Oncol Biol Phys 1998;42:1055–62.
  • Liotta LA, Kohn EC. The microenvironment of the tumour–host interface. Nature 2001;411:375–9.
  • Liotta LA, Paweletz CP. Invasion and metastasis. The cancer handbook. Alison M, editor. London: Nature; 2002.
  • Liotta LA, Stetler-Stevenson WG. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 1991;51:5054–9.
  • Opdenakker G, Cabeza-Arvelaiz Y, Fiten P. Human elongation factor 1 alpha: a polymorphic and conserved multigene family with multiple chromosomal localizations. Hum Genet 1987;75:339–44.
  • Condeelis J. Elongation factor 1 alpha, translation and the cytoskeleton. Trends Biochem Sci 1995;20:169–70.
  • Negrutskii BS, Deutscher MP. Channeling of aminoacyl-tRNA for protein synthesis in vivo. Proc Natl Acad Sci USA 1991;88:4991–5.
  • Edmonds BT, Wyckoff J, Yeung YG. Elongation factor-1a is an overexpressed actin binding protein in metastatic rat mammary adenocarcinoma. J Cell Sci 1996;109:2705–14.
  • Pecorari L, Marin O, Silvestri C. Elongation factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility. Mol Cancer 2009;8:58–69.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.